Innovative Treatment

Chair

Kapil Dhingra, M.D.
Clinical Science Leader
Hoffmann-La Roche

Members

Emmanuel Akporiaye, Ph.D.
Professor
Microbiology & Immunology
University of Arizona

Anna M. Casazza, Ph.D.
Oncology Consultant

James T. Dalton, Ph.D.
Associate Professor
Department of Pharmaceutical Sciences
University of Tennessee, Memphis

S. Gail Eckhardt, M.D.
Associate Professor
Division of Oncology
University of Colorado Health Science Center

Edward W. Gabrielson, M.D.
Associate Professor
Johns Hopkins Medical Institutes
Bayview Medical Center

Constantin G. Ioannides, Ph.D.
Associate Professor
Department of Gynecologic Oncology
University of Texas
M.D. Anderson Cancer Center

Barry M. Kacinski, M.D., Ph.D.
Professor
Department of Therapeutic Radiology
Yale University School of Medicine

William G. Kerr, Ph.D.
Associate Professor
Immunology Program
University of South Florida
Moffitt Cancer Center

Julia A. Lawrence, D.O.
Program Director
Division of Cancer Prevention
National Cancer Institute, NIH

Nitin T. Telang, Ph.D.
Director
Division of Carcinogenesis and Prevention
Strang Cancer Research Lab
Rockefeller University

Philip M. Toleikis, Ph.D.
Associate Director Pharmacology & Toxicology
Angiotech Pharmaceuticals, Inc.

Advocate Members

Susan M. Cohen, J.D.
SHARE and JALBCA

Margaree S. Crosby, Ed.D.
Greenville Cancer Society

California Advocate Observer Member

Vernal Branch
Women’s Cancer Task Force, Y-ME San Diego

Ad-Hoc Members

Donald E. Henson, M.D.
NCI Division of Cancer Prevention

Jerome P. Horwitz, Ph.D.
Professor
Meyer L. Prentiss Cancer Building
Karmanos Cancer Institute
Wayne State University

Duncan B. Neuhauser, Ph.D., M.B.A.
Professor of Medicine
Department of Epidemiology and Biostatstics
Case Western Reserve University